A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
- Conditions
- First Posted Date
- 2002-08-21
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Triangle Pharmaceuticals
- Target Recruit Count
- 30
- Registration Number
- NCT00044135
- Locations
- ๐ธ๐ฌ
National University Hospital, Division of Gastroenterology, Department of Medicine, Singapore, Singapore
๐จ๐ณPrince of Wales Hospital, Department of Medicine and Therapeutics, Hong Kong, China
๐บ๐ธUniversity of Illinois at Chicago, Chicago, Illinois, United States
Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Triangle Pharmaceuticals
- Target Recruit Count
- 390
- Registration Number
- NCT00002416
- Locations
- ๐บ๐ธ
Dr Robert Wallace, St. Petersburg, Florida, United States
๐บ๐ธNorth Shore Univ Hosp, Great Neck, New York, United States
A Study of MKC-442 in HIV-Positive Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Triangle Pharmaceuticals
- Registration Number
- NCT00002413
A Study of MKC-442 in Combination With Other Anti-HIV Drugs
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Triangle Pharmaceuticals
- Registration Number
- NCT00002412
- Locations
- ๐บ๐ธ
Dr Robert Wallace, St. Petersburg, Florida, United States
A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Triangle Pharmaceuticals
- Registration Number
- NCT00006208
- Locations
- ๐บ๐ธ
East Bay Clinical Trial Ctr, Concord, California, United States
๐บ๐ธOrange Coast Med Group, Newport Beach, California, United States
๐บ๐ธHealth Positive, Safety Harbor, Florida, United States
A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Triangle Pharmaceuticals
- Registration Number
- NCT00002362
- Locations
- ๐บ๐ธ
Northstar Med Clinic, Chicago, Illinois, United States
๐บ๐ธHouston Clinical Research Network, Houston, Texas, United States
๐บ๐ธUniv of Texas / Med School at Houston, Houston, Texas, United States
Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Triangle Pharmaceuticals
- Target Recruit Count
- 100
- Registration Number
- NCT00017992
- Locations
- ๐บ๐ธ
USC School of Medicine / LA County Med Ctr, Los Angeles, California, United States
๐บ๐ธUniv of Miami, Miami, Florida, United States
๐ฒ๐ฝInstituto Mexicano de Investigacion Clinica, Col Roma, Mexico
A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Triangle Pharmaceuticals
- Registration Number
- NCT00002215
- Locations
- ๐บ๐ธ
Anderson Clinical Research, Pittsburgh, Pennsylvania, United States